1. Home
  2. SCPH vs NNOX Comparison

SCPH vs NNOX Comparison

Compare SCPH & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • NNOX
  • Stock Information
  • Founded
  • SCPH 2013
  • NNOX 2011
  • Country
  • SCPH United States
  • NNOX Israel
  • Employees
  • SCPH N/A
  • NNOX N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • NNOX Medical Electronics
  • Sector
  • SCPH Health Care
  • NNOX Health Care
  • Exchange
  • SCPH Nasdaq
  • NNOX Nasdaq
  • Market Cap
  • SCPH 299.0M
  • NNOX 248.7M
  • IPO Year
  • SCPH 2017
  • NNOX 2020
  • Fundamental
  • Price
  • SCPH $5.63
  • NNOX $3.91
  • Analyst Decision
  • SCPH Buy
  • NNOX Strong Buy
  • Analyst Count
  • SCPH 3
  • NNOX 2
  • Target Price
  • SCPH $12.00
  • NNOX $8.50
  • AVG Volume (30 Days)
  • SCPH 2.3M
  • NNOX 1.1M
  • Earning Date
  • SCPH 11-12-2025
  • NNOX 08-12-2025
  • Dividend Yield
  • SCPH N/A
  • NNOX N/A
  • EPS Growth
  • SCPH N/A
  • NNOX N/A
  • EPS
  • SCPH N/A
  • NNOX N/A
  • Revenue
  • SCPH $49,969,000.00
  • NNOX $11,886,000.00
  • Revenue This Year
  • SCPH $108.95
  • NNOX $24.12
  • Revenue Next Year
  • SCPH $78.30
  • NNOX $160.56
  • P/E Ratio
  • SCPH N/A
  • NNOX N/A
  • Revenue Growth
  • SCPH 107.79
  • NNOX 17.36
  • 52 Week Low
  • SCPH $1.94
  • NNOX $3.63
  • 52 Week High
  • SCPH $6.28
  • NNOX $11.00
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 64.37
  • NNOX 42.28
  • Support Level
  • SCPH $4.33
  • NNOX $3.77
  • Resistance Level
  • SCPH $5.62
  • NNOX $4.03
  • Average True Range (ATR)
  • SCPH 0.05
  • NNOX 0.16
  • MACD
  • SCPH 0.01
  • NNOX 0.04
  • Stochastic Oscillator
  • SCPH 93.75
  • NNOX 63.95

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.

About NNOX NANO-X IMAGING LTD

Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.

Share on Social Networks: